"Heart Failure" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Descriptor ID |
D006333
|
| MeSH Number(s) |
C14.280.434
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Heart Failure".
Below are MeSH descriptors whose meaning is more specific than "Heart Failure".
This graph shows the total number of publications written about "Heart Failure" by people in this website by year, and whether "Heart Failure" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1997 | 3 | 1 | 4 |
| 1998 | 2 | 3 | 5 |
| 1999 | 6 | 1 | 7 |
| 2000 | 5 | 1 | 6 |
| 2001 | 8 | 0 | 8 |
| 2002 | 19 | 1 | 20 |
| 2003 | 22 | 3 | 25 |
| 2004 | 18 | 5 | 23 |
| 2005 | 24 | 6 | 30 |
| 2006 | 28 | 8 | 36 |
| 2007 | 25 | 5 | 30 |
| 2008 | 39 | 7 | 46 |
| 2009 | 32 | 8 | 40 |
| 2010 | 42 | 8 | 50 |
| 2011 | 36 | 12 | 48 |
| 2012 | 39 | 16 | 55 |
| 2013 | 51 | 8 | 59 |
| 2014 | 42 | 8 | 50 |
| 2015 | 60 | 12 | 72 |
| 2016 | 55 | 18 | 73 |
| 2017 | 64 | 12 | 76 |
| 2018 | 76 | 9 | 85 |
| 2019 | 63 | 12 | 75 |
| 2020 | 89 | 7 | 96 |
| 2021 | 79 | 10 | 89 |
| 2022 | 95 | 2 | 97 |
| 2023 | 122 | 1 | 123 |
| 2024 | 67 | 17 | 84 |
| 2025 | 52 | 9 | 61 |
| 2026 | 35 | 11 | 46 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heart Failure" by people in Profiles.
-
Short and long-term outcomes of intermediate-high risk pulmonary embolism treated with catheter-directed reperfusion therapy versus anticoagulation. Respir Med. 2026 Nov; 263:109186.
-
Alpha-ketoglutarate dehydrogenase and citric acid cycle flexibility in heart disease and failure. Am J Physiol Heart Circ Physiol. 2026 Nov 01; 331(5):H1631-H1649.
-
Comparing diagnostic tools for heart failure with preserved ejection fraction across community and clinical cohorts. Heart. 2026 Sep 24; 112(20):1153-1162.
-
Key elements of left ventricular assist device adjustment: A qualitative exploratory study. Heart Lung. 2026 Nov; 80:102954.
-
European Journal of Heart Failure International Expert Position Paper-Utilization, optimization, and clinical benefits of steroidal mineralocorticoid receptor antagonists in heart failure with a reduced ejection fraction. Eur J Heart Fail. 2026 Sep 15; 28(3):513-534.
-
Skeletal Muscle Dysfunction in Heart Failure: Mechanistic Insights and Therapeutic Implications. JACC Heart Fail. 2026 Nov; 14(11):103353.
-
Hypoxemic respiratory failure in patients with acute heart failure. Intern Emerg Med. 2026 Oct; 21(7):2733-2743.
-
Impact of personalized risk communication on patient understanding and decision-making in LVAD therapy. Patient Educ Couns. 2026 Dec; 153:109844.
-
Defining Clinically Meaningful Within-Patient Changes in Heart Failure: JACC: Heart Failure Position Statement. JACC Heart Fail. 2026 Oct; 14(10):103310.
-
Residual Inflammatory Risk of Heart Failure and Atherosclerotic CVD in Diabetes: Look AHEAD Ancillary Study. JACC Heart Fail. 2026 Nov; 14(11):103296.